|
|
Issue
|
|
 This issue is open to the public.
|
Alert me when new journal issues are available via  or via  |
|
|
| Alzheimer's & Dementia: The Journal of the Alzheimer's Association |
| Volume 1, Issue 1, Supplement (July 2005) |
|
Search Within This Issue
|
| Alzheimer's Association International Conference on Prevention of Dementia: Early Diagnosis and Intervention
|
|
|
|
|
|
|
|
|
|
|
|
Genetic basis of cerebral amyloidosis
Rudolph Tanzi
page S1
Full Text |
Full-Text PDF (57 KB)
|
|
Natural history of amyloid-beta peptides in the CNS and periphery
Steven Younkin
page S1
Full Text |
Full-Text PDF (57 KB)
|
|
Oligomers/Protofibrials/ADDLs
Grant Krafft
page S1
Full Text |
Full-Text PDF (57 KB)
|
|
Amyloid immunotherapy, extra-CNS actions
David Holtzman
page S1
Full Text |
Full-Text PDF (57 KB)
|
|
Immunotherapy, intra and intra-CNS actions
Frank L. Heppner
pages S1-S2
Full Text |
Full-Text PDF (66 KB)
|
|
Functional GAG mimetics as an approach for the treatment of amyloid diseases
Patrick Tremblay, Paul Aisen, Denis Garceau
page S2
Full Text |
Full-Text PDF (46 KB)
|
|
Modifiers of cholesterol metabolism
Dora M. Kovacs
page S2
Full Text |
Full-Text PDF (46 KB)
|
|
Alpha secretase
Joseph Buxbaum
page S2
Full Text |
Full-Text PDF (46 KB)
|
|
Presenilin/Gamma secretase as a therapeutic target
Michael S. Wolfe
page S2
Full Text |
Full-Text PDF (46 KB)
|
|
BACE
Philip Wong
page S3
Full Text |
Full-Text PDF (47 KB)
|
|
Commonly available modifiers of amyloid metabolism: Curry, fatty acids and NSAIDs
Greg M. Cole, Sally Frautsc
page S3
Full Text |
Full-Text PDF (47 KB)
|
|
Antagonists of metal-dependent oxidation and protein interactions
Ashley I. Bush
page S3
Full Text |
Full-Text PDF (47 KB)
|
|
Clinical trials of anti-amyloid agents
Paul S. Aisen
page S3
Full Text |
Full-Text PDF (47 KB)
|
|
Basic principles of MRI
Alan Koretsky
page S3
Full Text |
Full-Text PDF (47 KB)
|
|
Basic principles of spectroscopy, and perfusion weighted imaging
Norbert W. Schuff
page S4
Full Text |
Full-Text PDF (43 KB)
|
|
Basic principles of fMRI
Jozef (Jeff) H. Duyn
page S4
Full Text |
Full-Text PDF (43 KB)
|
|
Basic principles of FDG PET
William Jagust
page S4
Full Text |
Full-Text PDF (43 KB)
|
|
Basic principles of amyloid PET imaging
Mark A. Mintun
page S4
Full Text |
Full-Text PDF (43 KB)
|
|
Image processing
Derek Hill
page S4
Full Text |
Full-Text PDF (43 KB)
|
|
Imaging the hippocampal formation in the early diagnosis of Alzheimer’s disease
Mony J. de Leon, Lisa Mosconi, Susan de Santi, Wai Tsui, Henry Rusinek
pages S4-S5
Full Text |
Full-Text PDF (56 KB)
|
|
fMRI features of AD: Distinguishing Alzheimer’s disease from normal aging and other dementias with fMRI
Reisa Sperling
page S5
Full Text |
Full-Text PDF (48 KB)
|
|
Imaging Alzheimer’s disease and other dementias with PET
Norman L. Foster
page S5
Full Text |
Full-Text PDF (48 KB)
|
|
The application of amyloid-imaging to the diagnosis and treatment of Alzheimer’s disease
William E. Klunk, Julie C. Price, Steven T. DeKosky, Chester A. Mathis
page S5
Full Text |
Full-Text PDF (48 KB)
|
|
Early detection and monitoring with MRI
Michael Weiner
page S6
Full Text |
Full-Text PDF (45 KB)
|
|
MRI: Appearance of different dementias and their longitudinal changes
Nick Fox
page S6
Full Text |
Full-Text PDF (45 KB)
|
|
The relationship between amyloid load, microglial activation, and cognition in Alzheimer’s disease: PET findings
David Brooks, P. Edison, H. Archer, R. Hinz, A. Gerhard, A. Hammers, N. Pavese, Yf. Tai, D. Cuttler, N. Fox, M. Rossor, D. Brooks
page S6
Full Text |
Full-Text PDF (45 KB)
|
|
PET and MR imaging in dementia prediction and diagnosis
William Jagust
page S6
Full Text |
Full-Text PDF (45 KB)
|
|
Amyloid imaging with Pittsburgh Compound B
Chester A. Mathis, William E. Klunk, Julie C. Price, Steven T. DeKosky
pages S6-S7
Full Text |
Full-Text PDF (66 KB)
|
|
MRI-based methods for diagnosing and measuring progression of AD
Harald Hampel, Michael Ewers, Arun Bokde, Stefan Teipel
page S7
Full Text |
Full-Text PDF (58 KB)
|
|
Cortical thickness in Alzheimer’s disease
Alan C. Evans, Jason P. Lerch, Jens Pruessner, Alex P. Zijdenbos, Stefan J. Teipel, Harald Hampel
page S7
Full Text |
Full-Text PDF (58 KB)
|
|
Advanced MRI
Alan Koretsky
page S8
Full Text |
Full-Text PDF (45 KB)
|
|
Biomarkers 101
John Growdon
page S8
Full Text |
Full-Text PDF (45 KB)
|
|
CSF biomarkers
Henrik Zetterberg, Kaj Blennow
page S8
Full Text |
Full-Text PDF (45 KB)
|
|
Plasma biomarkers in Alzheimer’s disease diagnostic
Domenico Pratico
pages S8-S9
Full Text |
Full-Text PDF (59 KB)
|
|
Regulatory issues
page S9
Full Text |
Full-Text PDF (50 KB)
|
|
Cognitive ERPs as biomarkers and predictors of dementia in mild cognitive impairment (MCI)
John M. Olichney, James Gatherwright, Jason R. Taylor, David P. Salmon, Marta Kutas, Vicente J. Iragui
page S9
Full Text |
Full-Text PDF (50 KB)
|
|
Proton magnetic resonance spectroscopy in Alzheimer’s mouse model
Malgorzata Marjanska, Geoffry L. Curran, Thomas M. Wengenack, Joseph F. Poduslo, Clifford R. Jack, Michael Garwood, Kamil Ugurbil
page S9
Full Text |
Full-Text PDF (50 KB)
|
|
EEG BIS-AD correlates with metrics of cognitive function in healthy subjects and in patients with Alzheimer’s disease
Andrew F. Leuchter, Scott D. Greenwald, Vikas Saini, Janet Lawrence, Charles P. Smith, Philip H. Devlin
page S10
Full Text |
Full-Text PDF (49 KB)
|
|
Higher plasma IGF-I levels are associated with better cognitive performance in older women without diabetes
Olivia I. Okereke, Francine Grodstein
page S10
Full Text |
Full-Text PDF (49 KB)
|
|
AB42 peptides, tau, and P-tau181P as biomarkers for early diagnosis: A multiparametric approach using xMAP™ technology
Hugo M. Vanderstichele, Annika Olsson, Vesna Kostanjevecki, Kaj Blennow, Eugeen Vanmechelen
page S10
Full Text |
Full-Text PDF (49 KB)
|
|
Novel multiplexed CSF biomarkers for antemortem Alzheimer’s diagnosis
Kelvin Lee, Erin Finehout, Leila Choe, Zsofia Franck, Norman Relkin
pages S10-S11
Full Text |
Full-Text PDF (59 KB)
|
|
Direct measurement of adhesive forces in amyloid beta peptide structures
Norma A. Alcantar, Jeffy Jiménez, David Morgan
page S11
Full Text |
Full-Text PDF (48 KB)
|
|
The development of psoriasin as a novel therapeutic agent in Alzheimer’s disease
Weiping Qin, Lap Ho, Giulio M. Pasinetti
page S11
Full Text |
Full-Text PDF (48 KB)
|
|
The translational control of peripheral cells is correlated with the decline of cognitive tests in Alzheimer’s disease
Marc Paccalin, Stephanie Pain Barc, Claudette Pluchon, Chloé Paul, Hélène Bazin, Roger Gil, Jacques Hugon
page S11
Full Text |
Full-Text PDF (48 KB)
|
|
Predictive accuracy of the extended Predementia Alzheimer disease Scale (PAS) for Alzheimer-type dementia in subjects with MCI
Pieter Jelle Visser, Niki Schoonenboom, Jaap Lindeboom, Femke Bouwman, Laura van de Pol, Marien A. Blankenstein, Philip Scheltens
page S12
Full Text |
Full-Text PDF (49 KB)
|
|
Plasma AB levels as a premorbid biomarker for cognitive decline, mild cognitive impairment (MCI) and Alzheimer disease (AD)
Neill R. Graff-Radford, John A. Lucas, Julia E. Crook, Bradley F. Boeve, David S. Knopman, Robert J. Ivnik, Linda H. Younkin, Ronald C. Petersen, Steven G. Younkin
page S12
Full Text |
Full-Text PDF (49 KB)
|
|
Early markers of Alzheimer’s disease in patients with minimal to mild cognitive impairment
D.P. Devanand, Matthias H. Tabert, Gregory H. Pelton, Yaakov Stern
page S12
Full Text |
Full-Text PDF (49 KB)
|
|
Flow cytometric differentiation of oligomeric and fibrillar AB assembly states as biomarkers for Alzheimer’s disease
Michael Schaupp, Gerald Boehm, Lothar Trieschmann, Katja Kaschig, Falk Uschner, Claudia Schlittig, Sandra Torkler, Denny Nowak, Mingliang Li, Dietmar Mayer, Thomas Lauber, Alexander Navarrete Santos
pages S12-S13
Full Text |
Full-Text PDF (59 KB)
|
|
Natural killer (NK) cell activity as an early marker of Alzheimer’s disease: Results from a three year follow-up study
Paolo Prolo, Paola Perotti, Marisa Pautasso, Maria Luisa Sartori, Thomas Faccalini, Laura Saba, Fausto Fanto, Cristina Mocellini, Francesca Salvatico, Enzo Grasso
page S13
Full Text |
Full-Text PDF (50 KB)
|
|
Discovery, identification and validation of novel cerebrospinal fluid biomarkers of Alzheimer’s disease using SELDI-TOF mass spectrometry
Huw A. Davies, Anja Hviid Simonsen, Jim McGuire, Vladimir Podust, Niels Andreasen, Anders Wallin, Fujun Zhang, Gunhild Waldemar, Kaj Blennow
page S13
Full Text |
Full-Text PDF (50 KB)
|
|
Il-1A and M-CSF: Neurotoxic or neuroprotective markers in Alzheimer’s disease?
Olivera M. Mitrasinovic, Angela An Jou Chen, Heather Ryan, Connie Phong, Clara Poon, Greer M. Murphy
pages S13-S14
Full Text |
Full-Text PDF (66 KB)
|
|
Clinical proteomics to diagnose Alzheimer’s disease
Dwight C. German, Harold R. Garner, Ramon Diaz-Arrastia, Animesh Nandi, Prem Gurnani, Carol Moore, Kevin Rosenblatt
page S14
Full Text |
Full-Text PDF (55 KB)
|
|
The effects of gender on the relationship between body mass index and CSF AB42 and tau levels
Cynthia M. Carlsson, Carey E. Gleason, Kimberly Arnold, Tracy Ohrt, Rebecca Koscik, Angela Slattery, Sarah Meade, Mark Sager, Sanjay Asthana
page S14
Full Text |
Full-Text PDF (55 KB)
|
|
Plasma amyloid beta protein 42 in non-demented persons aged 75-years: Effects of concomitant medication and medial temporal lobe atrophy
Imrich Blasko, Joerg Kemmler, Wolfgang Krampla, Susanne Jungwirt, Ildigo Wichard, Kurt Jellinger, Karl Heinz Tragl, Peter Fischer
page S15
Full Text |
Full-Text PDF (48 KB)
|
|
P300 (latency) event-related potential: An accurate predictor of memory impairment : Hormonal correlates
Eric R. Braverman, Kenneth Blum
page S15
Full Text |
Full-Text PDF (48 KB)
|
|
Cystatin C as biological marker in mild cognitive impairment predicting for VAD
Roberta Ghidoni, Luisa Benussi, Aldo Villa, Simona Signorini, Anna Paterlini, Francesca Nicosia, Laura Barbiero, Giuliano Binetti
page S15
Full Text |
Full-Text PDF (48 KB)
|
|
A biomarkers and Alzheimer’s disease knowledge discovery tool
Sherrilynne S. Fuller, Debra Revere
pages S15-S16
Full Text |
Full-Text PDF (61 KB)
|
|
Dysregulation of cell cycle regulating proteins in peripheral lymphocytes in the patients with Alzheimer’s disease
Doh Kwan Kim, Hyeran Kim, Young Ah Kwon, Sung Ho Chung
page S16
Full Text |
Full-Text PDF (52 KB)
|
|
Modulated expressions in behavior and APP processing in transgenic mice overexpressing NSE-controlled APPsw
Jaeho Oh, Jungsik Cho, Sunbo Shim, Daeyoun Hwang, Seungwan Jee, Suhae Lee, JunSeo Goo, Sujin Seo, Yongkyu Kim
page S16
Full Text |
Full-Text PDF (52 KB)
|
|
Facials emotions and positive diagnosis of Alzheimer’s disease with (M.A.R.I.E.) Method of Analysis and Research of the Emotion Integration
Granato Philippe, Bruyer Raymond, Van Gansberghe Jean-Pierre
page S16
Full Text |
Full-Text PDF (52 KB)
|
|
|
|
|
|
|
|
